|
Get Full Access To This Report | or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
Auspex Pharmaceuticals, Inc.
Business Summary
Auspex Pharmaceuticals, Inc. is a privately-held, venture capital backed deuteration company. The clinical stage company develops medicines that improve safety and performance. The goal of the company's targeted deuteration strategy is to impart greater safety over existing agents, while maintaining or improving efficacy through the judicious use of deuterium as a replacement for metabolically labile hydrogen atoms. Auspex Pharmaceuticals has applied this targeted deuterations strategy to establish drug molecules across a range of therapeutic areas.. Founded in 2007 by Sepehr Sarshar and Manouchehr Shahbaz, Auspex Pharmaceuticals, Inc. is headquartered in La Jolla, California.
Overview & Corporate Organization
Basic Information
| Company Tags: | PE Backed VC Backed |
| Year Founded: | 2007 |
| Fiscal Year End: | 12/31 |
| 1YR Revenue Growth Rate: | View % |
| 1YR Employee Growth Rate: | View % |
| City: | La Jolla |
| State/Province: | California |
| Country: | United States |
| Phone: | View |
| Fax: | View |
| Website: | www.auspexpharma.com |
Corporate Organization
| Brands: | SD-254 |
| Founders: | Manouchehr Shahbaz Sepehr Sarshar |
Industry Information
PrivCo Industries (Sector > Industry > Sub-Industry)
| Technology > Biotechnology > Biopharmaceuticals |
| Technology > Biotechnology > Biotherapeutics |
The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.
Charts, Financials, and Statistics (Table Format)
Copy & Paste Financials Into Spreadsheet or
| Financial Notes: | |
| * | Auspex Pharmaceuticals, Inc. fiscal year end: 12/31 |
Charts, Financials, and Statistics (Graphs)
(Copy and paste into spreadsheet or export all Auspex Pharmaceuticals, Inc. financials to Excel and create your own graphs.)
To view the graphs below, unlock this company report for $99 or Upgrade to a PrivCo Premium Subscription for site-wide access to all PrivCo private company research reports.
Auspex Pharmaceuticals, Inc. Revenues ($): |
Auspex Pharmaceuticals, Inc. Total Employees: |
Auspex Pharmaceuticals, Inc. Productivity (Revenue/Employee) ($): |
VC/Funding Activity
| Date | Investor | Round | Investor Type | |
| May. 2008 | View | B | Private Equity | |
| May. 2008 | View | B | Venture Capital | |
| Details | Total Round B View | |||
| Dec. 2008 | View | Other | Venture Capital | |
| Dec. 2008 | View | Other | Venture Capital | |
| Details | Total Round Other View | |||
| Aug. 2009 | View | Debt Funding | Venture Capital | |
| Aug. 2009 | View | Debt Funding | Private Equity | |
| Details | Total Round Debt Funding View | |||
| Nov. 2009 | View | Debt Funding | Venture Capital | |
| Details | Total Round Debt Funding View | |||
| Feb. 2010 | View | Debt Funding | Venture Capital | |
| Details | Total Round Debt Funding1 View | |||
| Jul. 2010 | View | C | Venture Capital | |
| Jul. 2010 | View | C | Private Equity | |
| Jul. 2010 | View | C | Venture Capital | |
| Details | Total Round C View | |||
| Dec. 2011 | View | Debt Funding | Venture Capital | |
| Details | Total Round Debt Funding2 View | |||
| Nov. 2012 | View | D | Private Equity & Venture Capital | |
| Nov. 2012 | View | D | Private Equity | |
| Nov. 2012 | View | D | Venture Capital | |
| Nov. 2012 | View | D | Venture Capital | |
| Details | Total Round D View | |||
| Mar. 2013 | View | Debt Funding | Other Investment Firm | |
| Details | Total Round Debt Funding View | |||
| Total of Funding Shown Above View | ||||
| 1 | The issuance included promissory notes...Read More → |
| 2 | According to an SEC filing...Read More → |
Full-length notes are available with Single Report Access or PrivCo Premium Subscription. |
Missing a deal? Tell us about it! tips@privco.com
Supplemental Resources
|
Get Full Access To This Report | or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |







